Background: Antimicrobial Resistance (AMR) has been declared by WHO as one of the top 10 global health threats facing humanity and it becomes pertinent to find solutions to combat it. Drug resistant pathogens become rampant due to overuse or misuse of antimicrobials. Ayurveda has solutions for this above issue to prevent the use of antimicrobials. Conjunctivitis could manifest due to viral or bacterial or allergic etiology but Ayurveda always considered methods to enhance immunity to control these conditions in early stages.Starting early management in the prodromal stage described in Ayurveda, facilitates quick, inexpensive management and could be a solution to prevent prescribing antimicrobials.Methods and Assessment: Done with photos and teleconsultation in prodromal stage. Cases manifesting prodromal symptoms shared photos morning and evening.Questions recorded in detail confirmed prodromal symptoms, reduction or aggravation of symptoms was ensured. Results and Conclusion:Simple lifestyle, diet and Bidalaka (topical application) were suggested. More than 9 cases were recorded, significant results recorded in 3 to 4 days, nearly 6 cases responded only with the above. And 3 more cases prescribed oral consumption of Amruthasatwa 125 mg mixed with honey thrice a day. All symptoms cleared up in 4 to 5 days and usually without Ayurveda treatment it persists for 12 to 15 days. Management during prodromal stages ensures better outcomes.
COVID-19 patients have cutaneous manifestations such as herpes zoster, urticaria, chilblains, purpura, livedo racemosa, chickenpox-like eruptions in very small percentage. However, the major focus is on pulmonary and cardiac symptoms as it leads to increased mortality. Globally, many cases of herpes zoster as coinfection of COVID-19 are observed. Here, a 65-year-old female with Herpes Zoster Ophthalmicus (HZO) managed by Ayurveda stand-alone treatment is reported. She tested RT-PCR (Real-Time Polymerase Chain Reaction) positive, had mild COVID-19 symptoms, and preferred home isolation and Ayurveda treatment. The patient was monitored twice daily through teleconference (zoom/video calls), photographs of the condition were procured, and guidance was sent in return. Initially, the patient complained of fever, pain, and burning sensation in scalp, left ear, and eye with left periorbital swelling. Once the fever subsided, the patient developed vomiting and loose stools as COVID-19 symptoms. There was complete relief from all the symptoms in four weeks, and the medicines for the postherpetic lesions were continued for another week. Treatment of herpes coinfection in COVID-19 under home isolation is in itself a challenge requiring leech application. However, the case was managed with Ayurveda oral medications and topical therapies such as Seka and Bidalaka to achieve relief from pain, burning sensation, and swelling. The drugs and therapies used in the above case assisted increasing circulation relieving pain thereby, assuring good sleep and faster respite from all symptoms. This case is reported to add to clinical literature and to showcase the importance of local therapies and teleconsultation in condition like HZO associated with COVID-19.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.
customersupport@researchsolutions.com
10624 S. Eastern Ave., Ste. A-614
Henderson, NV 89052, USA
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Copyright © 2025 scite LLC. All rights reserved.
Made with 💙 for researchers
Part of the Research Solutions Family.